COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration

Bibliography

• O'BANION MK, COLEMAN PD, CALLAHAN LM: Regional neuronal loss in aging and Alzheimer's disease: a brief review. Sem. Neurosci. (1994) 6:307–314.
   Google Scholar
• SELKOE DJ: Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (1999) 399 (Suppl.):A23–A31.
   Google Scholar
• ••A concise review focusing on genetic and cell biologicprocesses contributing to AD.
   Google Scholar
• ALZHEIMER A: About a peculiar disease of the cerebral cortex. Allgemeine Zeitschrift fur Psychiatrie und Psychischt. Gerichliche Medizin (1907) 64:146.
   Google Scholar
• ROGERS J, O'BARR S: Inflammatory mediators in Alzheimer's disease. In: Molecular Mechanisms of Dementia. Wasco W, Tanzi RE, (Eds.) Humana Press, Inc., Totowa, NJ, USA (1997) 177–198.
   Google Scholar
• ••A broad overview of inflammation in AD.
   Google Scholar
• GRIFFIN WST, SHENG JG, ROYSTON MC et al.: Glial- neuronal interactions in Alzheimer's disease: the potential role of a `cytokine cycle' in disease progres-sion. Brain Pathol. (1998) 8:65–72.
   PubMed Web of Science ®Google Scholar
• •Review of inflammation in AD stressing A13 and IL-1 as specific components of an inflammatory cycle.
   Google Scholar
• MCGEER PL, MCGEER EG: Inflammation of the brain in Alzheimer's disease: implications for therapy. J. Leukoc. Biol. (1999) 65:409–415.
   PubMed Web of Science ®Google Scholar
• ••Another excellent review of inflammation in AD.
   Google Scholar
• MEDA L, CASSATELLA MA, SZENDREI GI et al.: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 374:647–650.
   PubMed Web of Science ®Google Scholar
• KOPEC KK, CARROLL RT: Alzheimer's 6-amyloid peptide 1-42 induces a phagocytic response in murine microglia. j Neurochem. (1998) 71:2123–2131.
   PubMed Web of Science ®Google Scholar
• GITTER BD, COX LM, RYDEL RE, MAY PC: Amyloid peptide potentiates cytokine secretion by interleukin-16-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA (1995) 92:10738–10741.
   PubMed Web of Science ®Google Scholar
• ROSSI F, BIANCHINI E: Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem. Biophy. Res. Comm. (1996) 225:474–478.
   PubMed Web of Science ®Google Scholar
• HU J, AKAMA KT, KRAFFT GA, CHROMY BA, VAN ELDIK LJ: Amyloid-6 peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. (1998) 785:195–206.
   PubMed Web of Science ®Google Scholar
• WEBSTER S, BRADT B, ROGERS J, COOPER N: Aggrega-tion state-dependent activation of the classical complement pathway by the amyloid beta peptide. J. Neurochem. (1997) 69:388–398.
   PubMed Web of Science ®Google Scholar
• WEBSTER S, LUE LF, BRACHOVA L et al: Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging (1997) 18:415–421.
   PubMed Web of Science ®Google Scholar
• •A thorough demonstration of complement activation in AD.
   Google Scholar
• GOLDGABER D, HARRIS HH, HLA T et al.: Interleukin 1 regulates synthesis of amyloid 6-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA (1989) 86:7606–7610.
   PubMed Web of Science ®Google Scholar
• DONNELLY RJ, FRIEDHOFF AJ, BEER B, BLUME AJ, VITEK MP: Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell. Mol. Neurobiol. (1990) 10:485–495
   PubMed Web of Science ®Google Scholar
• BRUGG B, DUBREUIL YL, HUBER G, WOLLMAN EE, DELHAYE-BOUCHARD N, MARIANA J: Inflammatory processes induce 6-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA (1995) 92:3032–3035.
   PubMed Web of Science ®Google Scholar
• COTMAN CW, TENNER AJ, CUMMINGS BJ: 6-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging (1996) 17:723–731.
   PubMed Web of Science ®Google Scholar
• MCGEER E.G., MCGEER PL: Inflammatory cytokines in the CNS. CNS Drugs (1997) 7:214–287.
   Web of Science ®Google Scholar
• FRAUTSCHY SA, YANG F, IRRIZARRY M et al.: Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. (1998) 152:307–317.
   PubMed Web of Science ®Google Scholar
• ROGERS J, WEBSTER S, LUE L-F et al.: Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging (1996) 17:681–686.
   PubMed Web of Science ®Google Scholar
• LUE LF, BRACHOVA L, CIVIN WH, ROGERS J: Inflamma-tion, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol Exp. Neurol. (1996) 55:1083–1088.
   PubMed Web of Science ®Google Scholar
• •Experimental evidence that AD requires an inflammatory response.
   Google Scholar
• BREITNER JCS: Inflammatory processes and antiin- flammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging (1996) 17:789–794.
   PubMed Web of Science ®Google Scholar
• ••Review of epidemiological studies with an excellent discus-sion of caveats.
   Google Scholar
• JENKINSON ML, BLISS MR, BRAIN AT, SCOTT DL: Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br. J. Rheumatol. (1989) 28:86–88.
   PubMedGoogle Scholar
• MCGEER PL, MCGEER E, ROGERS J, SIBLEY J: Anti-inflammatory drugs and Alzheimer's disease. Lancet (1990) 335:1037.
   PubMed Web of Science ®Google Scholar
• BREITNER JCS, WELSH KA, HELMS MJ etal.: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine 112 blocking drugs. Neurobiol. Aging (1995) 16:523–530.
   Google Scholar
• MCGEER PL, SCHULZER M, MCGEER EG: Arthritis andanti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemi-ological studies. Neurology (1996) 47:425–432.
   PubMed Web of Science ®Google Scholar
• •Brings epidemiological data together in a unique way.
   Google Scholar
• STEWART WF, KAWAS C, CORRADA M, METTER EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 48:626–632.
   PubMed Web of Science ®Google Scholar
• •First prospective study in a large population demonstrating benefits of NSAIDs in prevention of AD.
   Google Scholar
• ROGERS J, KIRBY LC, HEMPELMAN SR et al.: Clinical trial of indomethacin in Alzheimer's disease. Neurology (1993) 43:1609–1611.
   PubMed Web of Science ®Google Scholar
• ••Small, but important first trial of NSAIDs in AD treatment.
   Google Scholar
• RICH JB, RASMUSSON DX, FOLSTEIN MF, CARSON KA, KAWAS C, BRANDT J: Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 45:51–55.
   PubMed Web of Science ®Google Scholar
• AISEN PS, PASINETTI GM: Glucocorticoids in Alzheimer's disease. The story so far. Drugs & Aging (1998) 12:1–6.
   PubMed Web of Science ®Google Scholar
• VANE JR: Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature (1971) 231:232–235.
   Web of Science ®Google Scholar
• KUJUBU DA, FLETCHER BS, VARNUM BC, LIM RW, HERSCHMANN HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxyge-nase homologue. J. Biol. Chem. (1991) 266:12866–12872.
   PubMed Web of Science ®Google Scholar
• O'BANION MK, SADOWSKI HB, WINN V, YOUNG DA: Aserum- and glucocorticoid-regulated 4 kb mRNA encodes a cyclooxygenase related protein. J. Biol. Chem. (1991) 266:23261–23267.
   PubMed Web of Science ®Google Scholar
• XIE W, CHIPMAN JG, ROBERTSON DL, ERIKSON RU, SIMMONS DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA (1991) 88:2692–2696.
   PubMed Web of Science ®Google Scholar
• FU J-Y, MASFERRER JL, SEIBERT K, RAZ A, NEEDLEMAN P:The induction and suppression of prostaglandin 112 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. (1990) 265:16737–16740.
   PubMed Web of Science ®Google Scholar
• HAN J-W, SADOWSKI H, YOUNG DA, MACARA IG: Persis-tent induction of cyclooxygenase in p60'"c-transformed 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA (1990) 87:3373–3377.
   PubMed Web of Science ®Google Scholar
• MASFERRER JL, ZWEIFEL BS, SEILBERT K, NEEDLEMAN P:Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest. (1990) 86:1375–1379.
   PubMed Web of Science ®Google Scholar
• O'BANION MK, WINN VD, YOUNG DA: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA (1992) 89:4888–4892.
   PubMed Web of Science ®Google Scholar
• SMITH WL, DEWITT DL: Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol. (1996) 62:167–215.
   PubMed Web of Science ®Google Scholar
• HERSCHMAN HR, REDDY ST, XIE W: Function and regulation of prostaglandin synthase-2. Adv. Exp. Med. Biol. (1997) 407:61–66.
   PubMed Web of Science ®Google Scholar
• DUBOIS RN, ABRAMSON SB, CROFFORD L et al.: Cyclooxygenase in biology and disease. FASEBJ (1998) 12:1063–1073.
   PubMed Web of Science ®Google Scholar
• ••Highly readable review of current literature linking COX-2to disease processes.
   Google Scholar
• O'BANION MK: Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. (1999) 13:45–82.
   PubMed Web of Science ®Google Scholar
• •Thorough review of COX-2 neurobiology.
   Google Scholar
• SINGH G, TRIADAFILOPOULOS GT: Epidemiology of NSAID induced gastrointestinal complications. J. Rheumatol. (1999) 26 (Suppl. 56):18–24.
   Google Scholar
• NARUMIYA S: Prostanoid receptors: structure, function, and distribution. Ann. NY Acad. Sci. (1994) 744:126–138.
   PubMed Web of Science ®Google Scholar
• FORMAN BM, TONTONOZ P, CHEN J, BRUN RP, SPIEGELMAN BM, EVANS RM: 15-Deoxy-12, 14-prostagla-ndin J2 is a ligand for the adipocyte determination factor PPARy. Cell (1995) 83:803–812.
   PubMed Web of Science ®Google Scholar
• KLIEWER SA, LENHARD JM, WILLSON TM, PATEL I, MORRIS DC, LEHMANN JM: A prostaglandin J2 metabo-lite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell (1995) 85:813–819.
   Web of Science ®Google Scholar
• DENNIS EA: The growing phospholipase Ay superfamily of signal transduction enzymes. Trends Biochem. Sci. (1997) 22:1–2.
   PubMed Web of Science ®Google Scholar
• •Introduction to the isoforms of PLA2, by an expert in the field.
   Google Scholar
• MURAKAMI M, NAKATANI Y, ATSUMI G, INOUE K, KUDO I: Regulatory functions of phospholipase Ay. Crit. Rev. Immunol. (1997) 17:225–283.
   PubMed Web of Science ®Google Scholar
• •Thorough review of PLA2 isoforms emphasizing links to cyclooxygenase pathways.
   Google Scholar
• JAKOBSSON P-J, THORN S, MORGENSTERN R, SAMUELSSON B: Identification of human prosta-glandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA (1999) 96:7220–7225.
   PubMed Web of Science ®Google Scholar
• REDDY ST, HERSCHMAN HR: Prostaglandin synthase-1and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J. Biol. Chem. (1997) 272:3231–3237.
   PubMed Web of Science ®Google Scholar
• KUWATA H, NAKATANI Y, MURAKAMI M, KUDO I: Cytosolic phospholipase A2 is required for cytokine-induced expression of Type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. (1998) 273:1733–1740.
   PubMed Web of Science ®Google Scholar
• BALSINDE J, BALBOA MA, DENNIS EA: Functionalcoupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase Ay. J. Biol. Chem. (1998) 95:7951–7956.
   Google Scholar
• BROCK TG, MCNISH RW, PETERS-GOLDEN M: Arachi-donic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin Ey. J. Biol. Chem. (1999) 274:11660–11666.
   PubMed Web of Science ®Google Scholar
• CROFFORD LJ, WILDER RL, RISTIMAKI AP et al.:Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-10, phorbol ester, and corticosteroids. J. an. Invest. (1994) 93:1095–1101.
   PubMed Web of Science ®Google Scholar
• ANDERSON GD, HAUSER SD, MCGARITY KL, BREMER ME, ISAKSON PC, GREGORY SA: Selective inhibition of cyclooxygenase (C030-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. (1996) 97:2672–2679.
   PubMed Web of Science ®Google Scholar
• BLOM MAA, VAN TWILLET MGH, DE VRIES SC et al.: NSAIDS inhibit the IL-10-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin Ey. Brain Res. (1997) 777:210–218.
   Google Scholar
• FIEBICH BL, HULL M, LIEB K, GYUFKO K, BERGER M, BAUER J: Prostaglandin Ey induces interleukin-6 synthesis in human astrocytoma cells. J. Neurochem. (1997) 68:704–709.
   PubMed Web of Science ®Google Scholar
• HINSON RM, WILLIAMS JA, SHACTER E: Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA (1996) 93:4885–4890.
   PubMed Web of Science ®Google Scholar
• WILLIAMS JA, SHACTER E: Regulation of macrophagecytokine production by prostaglandin Ey: distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. (1997) 272:25693–25699.
   PubMed Web of Science ®Google Scholar
• MERTZ PM, DEWITT DL, STETLER-STEVENSON WG, WAHL LM: Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. (1994) 269:21322–21329.
   Google Scholar
• STANIMIROVIC D, SHAPIRO A, WONG J, HUTCHISON J,DURKIN J: The induction of ICAM-1 in human cerebro-microvascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J. Neuroimmunol. (1997) 76:193–205.
   PubMed Web of Science ®Google Scholar
• PORTANOVA JP, ZHANG Y, ANDERSON GD et al.: Selective neutralization of prostaglandin Ey blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. (1996) 184:883–891.
   PubMed Web of Science ®Google Scholar
• •Remarkable demonstration of PGE2 role in inflammation.
   Google Scholar
• FUTAKI N, ARAI, I, HAMASAKA Y, TAKAHASHI S, HIGUCHI S, OTOMO S Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10) carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. (1993) 45:753–755.
   Google Scholar
• MASFERRER JL, ZWEIFEL BS, MANNING PT et al: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. ScL USA (1994) 91:3228–3232.
   PubMed Web of Science ®Google Scholar
• SEIBERT K, ZHANG Y, LEAHY K et al.: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. ScL USA (1994) 91:12013–12017.
   PubMed Web of Science ®Google Scholar
• MASAKI M, MATSUSHITA M, WAKITANI K: Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats. Inflamm. Res. (1998) 47:187–192.
   PubMed Web of Science ®Google Scholar
• LANE NE: Pain management in osteoarthritis: the role of COX-2 inhibitors. J. Rheumatol. (1997) 24 (Suppl. 49):20–24.
   Google Scholar
• LIPSKY PE, ISAKSON PC: Outcome of specific COX-2 inhibition in rheumatoid arthritis. J. Rheumatol. (1997) 24 (Suppl. 49):9–14.
   Google Scholar
• EHRICH EW, DALLOB A, DE LEPELEIRE I et al: Charac-terization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin. Pharmacol Ther. (1999) 65:336–347.
   PubMed Web of Science ®Google Scholar
• LUONG C, MILLER A, BARNETT J, CHOW J, RAMESHA C, BROWNER MF: Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Struc. Biol. (1996) 3:927–933.
   PubMedGoogle Scholar
• KURUMBAIL RG, STEVENS AM, GIERSE JK et al.: Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature (1996) 384:644–648.
   PubMed Web of Science ®Google Scholar
• DEWITT DL: COX-2-selective inhibitors: the new super aspirins. Mol Pharmacol. (1999) 55:625–631.
   PubMed Web of Science ®Google Scholar
• •Review of molecular and structural features allowing development of COX-2 selective drugs.
   Google Scholar
• HAWKEY CJ: COX-2 inhibitors. Lancet (1999) 353:307–314.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of COX-2 inhibitor pharmacology andclinical utility.
   Google Scholar
• LIPSKY PE, ABRAMSON SB, CROFFORD L, DUBOIS RN, SIMON LS, VAN DE PUTTE LBA: The classification of cyclooxygenase inhibitors. J. Rheumatol. (1998) 25:2298–2303.
   PubMed Web of Science ®Google Scholar
• GEIS GS: Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?j Rheumatol. (1999) 25 (Suppl. 26):31–36.
   Google Scholar
• KALGUTKAR AS, CREWS BC, ROWLINSON SW, GARNER C, SEIBERT K, MARNETT LJ: Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science (1998) 280:1268–1270.
   PubMed Web of Science ®Google Scholar
• YAMAGATA K, ANDREASSON KI, KAUFMANN WI, BARNES CA, WORLEY PF: Expression of a mitogen-inducible cyclooxygenase in brain neurons: regula-tion by synaptic activity and glucocorticoids. Neurone (1993) 11:371–386.
   PubMed Web of Science ®Google Scholar
• ••First demonstration of regulated neuronal COX-2expression.
   Google Scholar
• CHEN J, MARSH T, ZHANG JS, GRAHAM SH: Expressionof cyclooxygenase-2 in rat brain following kainate treatment. Neuroreport (1995) 6:245–248.
   PubMed Web of Science ®Google Scholar
• ADAMS J, COLLAW-MORAES Y, DE BELLEROCHE J: Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. (1996) 66:6–13.
   PubMed Web of Science ®Google Scholar
• MARCHESELLI VL, BAZAN NG: Sustained induction ofprostaglandin endoperoxide synthase-2 by seizures in hippocampus. J. Biol. Chem. (1996) 271:24794–24799.
   PubMed Web of Science ®Google Scholar
• TOCCO G, FREIRE-MOAR J, SCHREIBER SS, SAKHI SH,AISEN PS, PASINETTI GM: Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. (1997) 144:339–349.
   PubMed Web of Science ®Google Scholar
• O'BANION MK, OLSCHOWKA JA: Localization and distri-bution of cyclooxygenase-2 in brain tissue by immunocytochemistry. In: Prostaglandin Protocols. Lianos EA, (Eds.) Humana Press, Inc., Totowa, NJ (1999) Methods Mol. Med. 120: 55–66.
   Google Scholar
• HEWETT SJ, HEWETT JA: COX-2 contributes toNMDA-induced neuronal death in cortical cell cultures. Soc. Neurosci. Abstr. (1997) 23:1666.
   Google Scholar
• THORE CR, BEASLEY TC, BUSIJA DW: In vitro and in vivolocalization of prostaglandin H synthase in fetal sheep neurons. Neurosci. Lett. (1998) 242:29–32.
   PubMed Web of Science ®Google Scholar
• KAUFMANN WE, ANDREASSON KI, ISAKSON PC, WORLEY PF: Cyclooxygenases and the central nervous system. Prostaglandins (1997) 54:601–624.
   PubMed Web of Science ®Google Scholar
• •Highly readable review of literature.
   Google Scholar
• COLLAW-MORAES Y, ASPEY B, HARRISON M, DE BELLEROCHE J: Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia. J. Cereb. Blood Flow Met. (1996) 16:1366–1372.
   PubMed Web of Science ®Google Scholar
• NOGAWA S, ZHANG F, ROSS ME, IADECOLA C: Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. NeuroscL (1997) 17:2746–2755.
   PubMed Web of Science ®Google Scholar
• ••First demonstration that selective COX-2 inhibition attenu-ates ischaemic damage.
   Google Scholar
• SAIRANEN T, RISTIMAKI A, KARJALAINEN-LINDSBERG M-L, PAETAU A, KASTE M, LINDSBERG PJ: Cyclooxygenase-2 is induced globally in infarcted human brain. Ann. Neurol. (1998) 43:738–747.
   PubMed Web of Science ®Google Scholar
• MIETTINEN S, FUSCO FR, YRJANHEIKKI J eta].: Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through /V-methyl-D-aspartic acid-receptors and phospholi-pase A2. Proc. Natl. Acad. ScL USA (1997) 94:6500–6505.
   Google Scholar
• KNAPP DJ, CREWS FT: Induction of cyclooxygenase-2 in brain during acute and chronic ethanol treatment and ethanol withdrawal. Alcohol. Clin. Exp. Res. (1999) 23:633–643.
   PubMed Web of Science ®Google Scholar
• KAUFMANN WE, WORLEY PF, PEGG J, BREMER M, ISAKSON P: Cox-2, a synaptically-induced enzyme, is expressed by excitatory neurons at postsynaptic sites © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10) in rat cerebral cortex. Proc. Natl. Acad. Sci. USA (1996) 93:2317–2321.
   Google Scholar
• O'BANION MK, DUSEL JC, CHANG JW, KAPLAN MD, COLEMAN PD: Interleukin-10 induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. (1996) 66:2532–2540.
   PubMed Web of Science ®Google Scholar
• KYRKANIDES S, OLSCHOWKA JA, WILLIAMS JP, HANSENJT, O'BANION MK: TNEcc and IL-113 mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS injury. J. Neuroimmunol. (1999) 95:95–106.
   PubMed Web of Science ®Google Scholar
• CHANG JW, COLEMAN PD, O'BANION MK: Prosta-glandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol Aging (1996) 17:801–808.
   PubMed Web of Science ®Google Scholar
• THORE CR, NAM MJ, BUSIJA DW: Immunofluorescentlocalization of constitutive and inducible prosta-glandin H synthase in ovine astroglia. J. Comp. Neurol. (1996) 367:1–9.
   PubMed Web of Science ®Google Scholar
• BAUER MKA, LIEB K, SCHULZEOSTOHOFF K et al: Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. j Biochem. (1997) 243:726–731.
   PubMedGoogle Scholar
• MINGHETTI L, POLAZZI E, NICOLINI A, CREMINON C, LEVI G: Interferon gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. (1996) 66:1963–1970.
   PubMed Web of Science ®Google Scholar
• DEG1 R, BARI F, BEASLEY TC et al.: Regional distribution of prostaglandin H synthase-2 and neuronal nitric oxide synthase in piglet brain. Ped. Res. (1998) 43:683–689.
   Google Scholar
• HIRST WD, YOUNG KA, NEWTON R, ALLPORT VC, MARRIOTT DR, WILKIN GP: Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. (1999) 13:57–68.
   PubMed Web of Science ®Google Scholar
• SANDHYA TL, ONG WY, HORROCKS LA, FAROOQUI AA: A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res. (1998) 788:223–231.
   PubMed Web of Science ®Google Scholar
• TONAI T, TAKETANI Y, UEDA N et al.: Possible involve-ment of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats. J. Neurochem. (1999) 72:302–309.
   PubMed Web of Science ®Google Scholar
• YERMAKOVA AV, ROLLINS J, CALLAHAN LM, ROGERS J, O'BANION MK: Cyclooxygenase-1 in human Alzheimer's and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J. Neuropathol. Exp. Neurol (1999). In Press.
   Google Scholar
• •Detailed report of COX-1 in human brain.
   Google Scholar
• DEININGER M, SCHLUESENER HJ: Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma. J. Neuroimmunol. (1999) 95:202–208.
   PubMed Web of Science ®Google Scholar
• LI S, WANG Y, MATSUMURA K, BALLOU LR, MORHAM SG, BLATTEIS CM: The febrile response to lipopolysaccha-ride is blocked in cyclooxygenase-2-/-, but not in cyclooxygenase-1-/- mice. Brain Res. (1999) 825:86–94.
   PubMed Web of Science ®Google Scholar
• CAO C, MATSUMURA K, YAMAGATA K, WATANABE Y: Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. (1995) 697:187–196.
   PubMed Web of Science ®Google Scholar
• CAO C, MATSUMURA K, YAMAGATA K, WATANABE Y: Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-113: a possible site of prostaglandin synthesis responsible for fever. Brain Res. (1996) 733:263–272.
   PubMed Web of Science ®Google Scholar
• BREDER CD, SAPER CB: Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccha-ride. Brain Res. (1996) 713:64–69.
   PubMed Web of Science ®Google Scholar
• LACROIX S, RIVEST S: Effect of acute systemic inflamma-tory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. (1998) 70:452–466.
   PubMed Web of Science ®Google Scholar
• MATSUMURA K, CAO C, OZAKI M, MORII H, NAKADATE K, WATANABE Y: Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocyto-chemical studies. J. Neurosci. (1998) 18:6279–6289.
   PubMed Web of Science ®Google Scholar
• ELMQUIST JK, BREDER CD, SHERIN JE et al.: Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J. Comp. Neurol. (1997) 381:119–129.
   PubMedGoogle Scholar
• CAO C, MATSUMURA K, OZAKI M, WATANABE Y: Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells. J. Neurosci. (1999) 19:716–725.
   PubMed Web of Science ®Google Scholar
• CAO C, MATSUMURA K, YAMAGATA K, WATANABE Y: Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am. J. Physiol. (1997) 272:R1712–R1725.
   PubMed Web of Science ®Google Scholar
• CHAN C-C, PANNETON M, TAYLOR AM, THERIEN M, RODGER IW: A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates. Eur. J. Pharmacol (1997) 327:221–225.
   PubMed Web of Science ®Google Scholar
• BRIAN JE, JR., MOORE SA, FARACI FM: Expression and vascular effects of cyclooxygenase-2 in brain. Stroke (1998) 29:2600–2606.
   PubMed Web of Science ®Google Scholar
• OKAMOTO H, ITO 0, ROMAN RJ, HUDETZ AG: Role of inducible nitric oxide synthase and cyclooxygenase-2 in endotoxin-induced cerebral hyperemia. Stroke (1998) 29:1209–1218.
   PubMed Web of Science ®Google Scholar
• RICH G, YODER EJ, MOORE SA: Regulation of prosta-glandin H synthase-2 expression in cerebromicrovas-cular smooth muscle by serum and epidermal growth factor. J. Cell. Physiol. (1998) 176:495-505.v © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10)
   Google Scholar
• LUKIW WJ, BAZAN NG: Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. j Neurosci. Res. (1997) 50:937–945.
   PubMed Web of Science ®Google Scholar
• YASOJIMA K, SCHWAB C, MCGEER EG, MCGEER PL: Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res. (1999) 830:226–236.
   PubMed Web of Science ®Google Scholar
• PASINETTI GM, AISEN PS: Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience (1998) 87:319–324.
   PubMed Web of Science ®Google Scholar
• HO L, PIERONI C, WINGER D, PUROHIT DP, AISEN PS, PASINETTI GM: Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. (1999) 57:295–303.
   PubMed Web of Science ®Google Scholar
• •Semi-quantitative immunohistochemical analysis of COX-2 expression in human hippocampus.
   Google Scholar
• KITAMURA Y, SHIMOHAMA S, KOIKE H et al.: Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem. Biophys. Res. Comm. (1999) 254:582–586.
   PubMed Web of Science ®Google Scholar
• OKA A, TAKASHIMA S: Induction of cyclooxygenase 2 in brains of patients with Down's syndrome and dementia of the Alzheimer's type: specific localization in affected neurones and axons. Neuroreport (1997) 8:1161–1164.
   PubMed Web of Science ®Google Scholar
• OKA A, ITOH M, TAKASHIMA S: The early induction of cyclooxygenase 2 associated with neurofibrillary degeneration in brains of patients with Fukuyama-type congenital muscular dystrophy. Neuropediatrics (1999) 30:34–37.
   PubMed Web of Science ®Google Scholar
• IWAMOTO N, KOBAYASHI K, KOSAKA K: The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J. Neurol. (1989) 236:80–84.
   PubMed Web of Science ®Google Scholar
• WONG PT, MCGEER PL, MCGEER EG: Decreased prosta-glandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem. InL (1992) 21:197–202.
   PubMed Web of Science ®Google Scholar
• GOTTSCHALL P: Beta-amyloid induction of gelatinase B secretion in cultured microglia - inhibition by dexamethasone and indomethacin. Neuroreport (1996) 7:3077–3080.
   PubMed Web of Science ®Google Scholar
• JANABI N, HAU I, TARDIEU M: Negative feedback between prostaglandin and a- and 6-chemokine synthesis in human microglial cells and astroctyes. J. Immunol. (1999) 162:1701–1706.
   PubMed Web of Science ®Google Scholar
• BRAMBILLA R, BURNSTOCK G, BONAZZI A, CERUTI S, CATTABENI F, ABBRACCHIO MP: Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol (1999) 563–567.
   PubMed Web of Science ®Google Scholar
• MINGHETTI L, POLAZZI E, NICOLINI A, CRÉMINON C, LEVI G: Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin Ey, cyclic AMP, and non-steroidal anti-inflammatory drugs. Eur. J. Neurosci. (1997) 9:934–940.
   PubMed Web of Science ®Google Scholar
• MINGHETTI L, NICOLINI A, POLAZZI E, CRÉMINON C, MACLOUF J, LEVI G: Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin Ey and by cyclooxygenase inhibitors. Glia (1997) 19:152–160.
   PubMed Web of Science ®Google Scholar
• ALOISI F, DESIMONE R, COLUMBA-CABEZAS S, LEVI G: Opposite effects of interferon-y and prostaglandin Ey on tumor necrosis factor and interleukin-10 produc-tion in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory cytokines. J. Neurosci. Res. (1999) 56:571–580.
   PubMed Web of Science ®Google Scholar
• DASH PK, MOORE AN: Enhanced processing of APP induced by 11-16 can be reduced by indomethacin and nordihydroguaiaretic acid. Biochem. Biophys. Res. Comm. (1995) 208:542–548.
   PubMed Web of Science ®Google Scholar
• LEE RKK, KNAPP S, WURTMAN RJ: Prostaglandin Ey stimulates amyloid precussor protein gene expres-sion: inhibition by immunosuppressants. J. Neurosci. (1999) 19:940–947.
   PubMed Web of Science ®Google Scholar
• •Establishes an important link between PGE2 and APP expression.
   Google Scholar
• MACKENZIE IRA, MUNOZ DG: Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology (1998) 50:986–990.
   PubMed Web of Science ®Google Scholar
• NETLAND EE, NEWTON JL, MAJOCHA RE, TATE BA: Indomethacin reverses the microglial response to amyloid 6-protein. Neurobiol. Aging (1998) 19:201–204.
   PubMed Web of Science ®Google Scholar
• HAUSS-WEGRZYNIAK B, WILLARD LB, DEL SOLDATO P, PEPEU G, WENK GL: Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res. (1999) 815:36–43.
   PubMed Web of Science ®Google Scholar
• WAKITA H, TOMIMOTO H, AKIGUCHI I, LIN J-X, MIYAMOTO K, OKA N: A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. Neuroreport (1999) 10:1461–1465.
   PubMed Web of Science ®Google Scholar
• GRAHAM SH, KAWAGUCHI K, ZHU L, CHEN J: Cyclooxygenase-2 is induced in rat brain after kainate induced seizures and promotes neuronal death in CA3 hippocampus. Soc. Neurosci. Abstr. (1996) 22:2088.
   Google Scholar
• NOGAWA S, FORSTER C, ZHANG F, NAGAYAMA M, ROSS ME, IADECOLA C: Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc. Natl. Acad. ScL USA (1998) 95:10966–10971.
   PubMed Web of Science ®Google Scholar
• NAKAYAMA M, UCHIMURA K, ZHU RL et al.: Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. ScL USA (1998) 95:10954–10959.
   PubMed Web of Science ®Google Scholar
• SALVEMINI D: Regulation of cyclooxygenase enzymes by nitric oxide. Cell. MoL Life ScL (1997) 53:576–582.
   PubMed Web of Science ®Google Scholar
• DAWSON VL, DAWSON TM: Nitric oxide in neurodegen-eration. Prog. Brain Res. (1999) 118:215–229.
   Web of Science ®Google Scholar
• ELIASSON MJL, HUANG Z, FERRANTE RJ et al: Neuronal nitric oxide synthase activation and peroxynitrite © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10) formation in ischemic stroke linked to neural damage. NeuroscL (1999) 19:5910–5918.
   Google Scholar
• SMITH MA, RICHEY-HARRIS PL, SAYRE LM, BECKMAN JS, PERRY G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. NeuroscL (1997) 17:2653–2657.
   PubMed Web of Science ®Google Scholar
• KELLEY KA, HO L, WINGER D, FREIRE-MOAR J, AISEN PS, PASINETTI GM: Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. (1999) In Press.
   Google Scholar
• MORHAM SG, LANGENBACH R, LOFTIN CD et al: Prosta-glandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell (1995) 83:473–482.
   PubMed Web of Science ®Google Scholar
• GILROY DW, TOMLINSON A, WILLOUGHBY DA: Differ-ential effects of inhibition of isoforms of cyclooxyge-nase (COX-1, COX-2) in chronic inflammation. Inflamm. Res. (1998) 47:79–85.
   PubMed Web of Science ®Google Scholar
• SMITH CJ, ZHANG Y, KOBOLDT CM et al.: Pharma-cological analysis of cyclooxygenase-1 in inflamma-tion. Proc. Natl. Acad. Sci. USA (1998) 95:13313–13318.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, BAK A, MCKNIGHT W, ASFAHA S, SHARKEY KA, MACNAUGHTON WK: Cyclooxygenase-1 contrib-utes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenter-ology (1998) 115:101–109.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, CHAPMAN K, MCKNIGHT W: Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br. PharmacoL (1999) 126:1200–1204.
   PubMed Web of Science ®Google Scholar
• YIN MJ, YAMAMOTO Y, GAYNOR RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of IKB kinase-6. Nature (1998) 396:77–80.
   PubMed Web of Science ®Google Scholar
• MAGGIRWAR SB, SARMIERE PD, DEWHURST S, FREEMAN RS: Nerve growth factor-dependent activation of NF-KB contributes to survival of sympathetic neurons. J. Neurosci. (1998) 18:10256–10365.
   Web of Science ®Google Scholar
• LEHMANN JM, LENHARD JM, OLIVER BB, RINGOLD GM, KLEIWER SA: Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. (1997) 272:3406–3410.
   PubMed Web of Science ®Google Scholar
• JIANG C, TING AT, SEED B: PPAR-y agonists inhibit production of monocyte inflammatory cytokines. Nature (1998) 391:82–86.
   PubMed Web of Science ®Google Scholar
• •Demonstration that PGs provide feedback inhibition in inflammation.
   Google Scholar
• RICOTE M, LI AC, WILLSON TM, KELLY CJ, GLASS CK: The peroxisome proliferator-activated receptor-y is a negative regulator of macrophage activation. Nature (1998) 391:79–82.
   PubMed Web of Science ®Google Scholar
• ••Demonstration that PGs provide feedback inhibition ininflammation.
   Google Scholar
• KITAMURA Y, KAKIMURA J-I, MATSUOKA Y, NOMURA Y, GEBICKE-HAERTER PJ, TANIGUCHI T: Activators of peroxisome proliferator-activated receptor-g (PPARy) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. NeuroscL Lett. (1999) 262:129–132.
   PubMed Web of Science ®Google Scholar
• PETROVA TV, AKAMA KT, VAN ELDIK LJ: Cyclopente-none prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-12,14_ prostaglandin j2, Proc. Natl. Acad. ScL USA (1999) 96:4668–4673.
   PubMed Web of Science ®Google Scholar
• SHENK D, BARBOUR R, DUNN W et al: Immunization with amyloid-6 attenuates Alzheimer's-disease-like pathology in the PDAPP mouse. Nature (1999) 400:173–177.
   PubMed Web of Science ®Google Scholar
• ••Remarkable demonstration of a novel means to treat AD.
   Google Scholar
• SCHMIDLEY JW, DADSON J, IYER RS, SALOMON RG: Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2. Prostag. Leukotr. Ess. Fatty Acids (1992) 47:105–110.
   PubMed Web of Science ®Google Scholar
• DE LUSTIG ES, KOHAN S, FAMULARI AL, COMINGUEZ RO, SERRA JA: Peripheral markers and diagnostic criteria in Alzheimer's disease: critical evaluations. Rev. NeuroscL (1994) 5:213–225.
   PubMedGoogle Scholar
• DE LA TORRE JC: Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology (1997) 43:26–43.
   PubMed Web of Science ®Google Scholar
• SNOWDON DA, GREINER LH, MORTIMER JA, RILEY KP, GREINER PA, MARKESBERY WR: Brain infarction and the clinical expression of Alzheimer's disese: The Nun Study. JAMA (1997) 277:813–817.
   PubMed Web of Science ®Google Scholar
• CAZEVIELLE C, MULLER A, BONNE C: Prostacyclin (PGI2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. NeuroscL Let. (1993) 160:106–108.
   PubMed Web of Science ®Google Scholar
• MCADAM BF, CATELLA-LAWSON F, MARDINI IA, KAPOOR S, LAWSON JA, FITZGERALD GA: Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. ScL USA (1999) 96:272–277.
   PubMed Web of Science ®Google Scholar
• GILROY DW, COLVILLE-NASH PR, WILLIS D, CHIVERS J, PAUL-CLARKE MJ, WILLOUGHBY DA: Inducible cyclooxygenase may have anti-inflammatory proper-ties. Nature Med. (1999) 5:698–701.
   PubMed Web of Science ®Google Scholar
• PASINETTI GM: Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. NeuroscL Res. (1998) 54:1–6.
   PubMed Web of Science ®Google Scholar